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ETATE-OF-THE-ART PAPER539Cardiac Dysfunction in Patients With Cirrhosisnrico M. Zardi, Antonio Abbate, Domenico Maria Zardi, Aldo Dobrina, Domenico Margiotta,
enjamin W. Van Tassel, Antonella Afeltra, Arun J. Sanyal
p to 50% of cirrhotic patients undergoing liver transplantation show signs of cardiac
ysfunction, and many of the deaths in post-orthotopic liver transplantation are caused by
eart failure. In this state-of-the-art paper, Zardi and colleagues review the pathophysiology
nd clinical implications of cirrhotic cardiomyopathy. Cirrhotic cardiomyopathy is
haracterized by blunted contractile responsiveness to stress and/or altered diastolic relaxation.
here are currently no strict diagnostic criteria for cirrhotic cardiomyopathy, and this
yndrome is often not recognized. Because it blunts the body’s ability to increase cardiac
utput when necessary, for example, after paracentesis or a transjugular intrahepatic
ortosystemic shunt procedure, it is likely a cofactor of the hepatorenal syndrome and other
omplications of cirrhosis. A better understanding of the hemodynamic changes and their
olecular pathways may lead to improved outcomes for patients with cirrhosis.CLINICAL RESEARCH NTERVENTIONAL CARDIOLOGY
550imilar Outcomes for PCI With High-Dose
Clopidogrel Load Given In-Lab or Pre-Procedureermano Di Sciascio, Giuseppe Patti, Vincenzo Pasceri, Laura Gatto, Giuseppe Colonna, Antonio Montinaro,
n behalf of the ARMYDA-5 PRELOAD Investigators
he ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage
uring Angioplasty) trial compared loading clopidogrel pre-percutaneous coronary
ntervention (PCI) in the laboratory (in-lab) to routine 6-h pre-load prior to diagnostic
ngiography. A total of 409 patients (39% with acute coronary syndrome) were randomized
o receive a 600-mg clopidogrel loading dose 4 to 8 h before PCI (“pre-load” group) or a
00-mg loading dose after angiography, but prior to PCI (“in-lab” group). There was no
ignificant difference in the primary end point, which was the 30-day incidence of major
dverse cardiac events, including periprocedural myocardial infarction. The risk of bleeding or
ascular complications was also not different. These results suggest that in-lab clopidogrel
dministration may be a safe alternative to routine pre-treatment given before defining the
oronary anatomy.
ditorial Comment: Goran Stankovic, Milorad Zivkovic, p. 558(continued on page A-19)
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EARDIAC IMAGING561CMR to Detect Coronary Ischemia: Quantitative or Qualitative Analysismit R. Patel, Patrick F. Antkowiak, Kiran R. Nandalur, Amy M. West, Michael Salerno, Vishal Arora,
ohn Christopher, Frederick H. Epstein, Christopher M. Kramer
atel and colleagues compared quantitative cardiac magnetic resonance (CMR) first-pass
ontrast-enhanced perfusion imaging to qualitative interpretation for determining the presence
nd severity of coronary artery disease (CAD). For this study, the subjects received a
ontinuous adenosine infusion, and then a low dose of gadolinium was used to calculate the
erfusion reserve (PR) and the ratio of flow during hyperemia to baseline; this was followed
y a higher dose of gadolinium for qualitative interpretation (QI) by an experienced reader.
ll subjects underwent conventional angiography. PR decreased stepwise as coronary artery
tenosis (CAS) severity increased: 2.4 for 50% to 1.8 for 70%. PR and QI had similar
iagnostic accuracies for detection of CAS, but PR was more useful for detecting triple-vessel
AD. Quantitative perfusion reserve by CMR differentiates moderate from severe stenoses in
atients with known or suspected CAD and is particularly useful for identifying cases of
alanced ischemia.ALVULAR HEART DISEASE570LA Volume Predicts Outcomes in Patients With MRhierry Le Tourneau, David Messika-Zeitoun, Antonio Russo, Delphine Detaint, Yan Topilsky,
ouglas W. Mahoney, Rakesh Suri, Maurice Enriquez-Sarano
eft atrial (LA) enlargement is a consequence of mitral regurgitation (MR), but it is
nknown if LA volume can be used to identify patients at increased risk for cardiac events or
ortality. Le Tourneau and colleagues prospectively enrolled nearly 500 patients in sinus
hythm with organic MR. LA volume indexed to body surface area (LA index) was 40
l/m2 in one-third of subjects and 60 ml/m2 in another one-third. Compared to patients
ith LA index 40 ml/m2, those with LA index 60 ml/m2 were nearly 3 times more likely
o die and 5 times more likely to suffer a cardiac event with medical management. Mitral
urgery was associated with decreased mortality (hazard ratio [HR]: 0.46) and cardiac events
HR: 0.38) after surgery in patients with LA index 60 ml/m2. These results suggest that
A index 60 ml/m2 might be useful for identifying patients in need of mitral valve surgery.
ditorial Comment: Robert A. Levine, Stanley Nattel, p. 579(continued on page A-24)
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EEDIATRIC CARDIAC TRANSPLANTATION
582iral Endomyocardial Infection Associated With
Worse Outcomes in Pediatric Cardiac Transplant Recipients.2
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Predicted Graft Survival Curves for Individual Viruses
PCR- (n=57)
CMV+ (n=4)
Parvo+ (n=23)
Adeno+ (n=9)
EBV+ (n=8)
PCR neg
CMV+ (p=0.8)
Adeno+ (p=0.03)
Parvo+ (p=0.4)
EBV+ (p=0.002)
Years after cardiac transplantationousumi Moulik, John P. Breinholt, William J. Dreyer, Debra L. Kearney, Jack F. Price, Sarah K. Clunie,
rady S. Moffett, Jeffrey J. Kim, Joseph W. Rossano, John Lynn Jefferies, Karla R. Bowles, E. O’Brian Smith,
eil E. Bowles, Susan W. Denfield, Jeffrey A. Towbin
oulik and colleagues hypothesized that viral infection of the cardiac allograft reduces graft
urvival in pediatric cardiac transplant recipients and began testing all endomyocardial biopsy
EMB) samples with polymerase chain reaction (PCR) assays for several common viruses.
iral genomes were detected in 39% of patients; parvovirus B19, adenovirus, and Epstein-
arr virus were the most common. The PCR-positive group had decreased graft survival and
igher mortality compared with the PCR-negative group. This was mostly due to transplant
oronary artery disease and was not associated with acute rejection. Some of the patients who
ere PCR-positive were treated with intravenous immunoglobulin (IVIG), which seems to
ave improved outcomes. These results suggest that EMBs should be routinely tested for viral
nfection and that IVIG should be considered in those who test positive, although larger and
andomized trials are needed to confirm the effectiveness of IVIG.PRE-CLINICAL RESEARCH RE-CLINICAL RESEARCH593Human CD31 Cells May be Useful for Treating Ischemiaung-Whan Kim, Hyongbum Kim, Hyun-Jai Cho, Jung-Uek Lee, Rebecca Levit, Young-sup Yoon
D31 is a well-known marker for endothelial cells, but is also expressed in a fraction of
eripheral blood (PB) mononuclear cells. Kim and colleagues isolated CD31 cells from
uman PB and examined the gene expression profile by deoxyribonucleic acid microarray and
eal-time reverse transcriptase polymerase chain reaction. These cells had high levels of
xpression of pro-angiogenic genes and generated higher numbers of endothelial progenitor
ells compared with CD31 cells. In a mouse hindlimb ischemia model, CD31 cell
ransplantation augmented blood perfusion and prevented limb loss. CD31 is a novel marker
hat designates circulating angiogenic and vasculogenic cells, which are easily harvested and
ay be useful for treating chronic ischemia.ditorial Comment: Robert D. Simari, Rajiv Gulati, p. 608
